From: Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
Trial day 2
Trial day 3
Trial day 4
Pain
2.8 (0.7)
2.2 (1.1)
2.2 (1,1)
Nausea
1.7 (1.0)
1.7 (1.1)
1.8 (0.9)
Sedation
3.4 (1.2)
3.4 (1.0)
3.2 (1.1)